Filing Flows › Cryo Cell International (CCEL) › Q2 FY26
Cryo Cell International (CCEL) Q2 FY26 earnings results (second quarter fiscal 2026)
10-Q filed Jul 15, 2026
Cryo Cell International (CCEL) reported revenue of $7.8M for the second quarter fiscal 2026 (Q2 FY26), -2% from a year earlier and +1% from the quarter before. Operating margin was 15.4%, net earnings $555K (7.1% of revenue).
Cryo Cell International, Q2 FY26: revenue $7.8M (-2% year over year), operating margin 15.4%, net earnings $555K, operating cash flow $1.8M. The chart follows the revenue to costs, profit and cash.
| Q2 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.8M | +1% | -2% |
| Operating profit | $1.2M | +56% | -20% |
| Net earnings | $555K | 12× | +56% |
| Operating cash flow | $1.8M | +183% | +161% |
| Free cash flow | $1.8M | +210% | +181% |
What changed
Revenue was $7.8M in Q2 FY26, down 2% year over year and up 1% from the previous quarter. Processing and Storage Fees was the largest line at 99% of revenue. Processing and Storage Fees lost $156K year over year (down 2%), 102% of the total change.
Operating profit was $1.2M, a 15.4% margin (down 3.4 points year over year). Total costs grew 2% against a revenue fall of 2%. Net earnings were $555K, up 56% year over year. The effective tax rate was 33.0%.
Operating cash flow was $1.8M (up 161% year over year), 333% of net earnings. Non-cash charges added back $244K of depreciation and amortization and $65K of share-based compensation. Working capital and other items added $1.0M. Capital expenditures of $33K left free cash flow of $1.8M.
Questions
What was Cryo Cell International's revenue in the second quarter fiscal 2026?
Cryo Cell International (CCEL) reported revenue of $7.8M for the second quarter fiscal 2026 (Q2 FY26), -2% from a year earlier and +1% from the quarter before.
Was Cryo Cell International profitable in the second quarter fiscal 2026?
Operating profit was $1.2M (15.4% of revenue) and net earnings $555K.